These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8951349)

  • 1. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
    Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes.
    Grabowski DR; Dubyak GR; Rybicki L; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1998 Aug; 56(3):345-9. PubMed ID: 9744572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes.
    Aoyama M; Grabowski DR; Holmes KA; Rybicki LA; Bukowski RM; Ganapathi MK; Ganapathi R
    Biochem Pharmacol; 2001 Jan; 61(1):49-54. PubMed ID: 11137708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
    Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
    Wang SJ; Peyrollier K; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis.
    Vaziri SA; Grabowski DR; Tabata M; Holmes KA; Sterk J; Takigawa N; Bukowski RM; Ganapathi MK; Ganapathi R
    Anticancer Res; 2003; 23(5A):3657-61. PubMed ID: 14666661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
    Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
    Williams CL; Phelps SH; Porter RA
    Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N; Grabowski D; Ford J; Ganapathi R
    Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
    Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
    Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) .
    Williams CL; Porter RA; Phelps SH
    Biochem Pharmacol; 1995 Dec; 50(12):1979-85. PubMed ID: 8849323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of insulin secretion from permeabilized pancreatic beta-cells on the activation of Ca(2+)/calmodulin-dependent protein kinase II. A re-evaluation of inhibitor studies.
    Bhatt HS; Conner BP; Prasanna G; Yorio T; Easom RA
    Biochem Pharmacol; 2000 Dec; 60(11):1655-63. PubMed ID: 11077048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus.
    Fukushima T; Shimazoe T; Shibata S; Watanabe A; Ono M; Hamada T; Watanabe S
    Neurosci Lett; 1997 May; 227(1):45-8. PubMed ID: 9178855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of M3 muscarinic acetylcholine receptor-mediated Ca2+ influx and intracellular Ca2+ mobilization in neuroblastoma cells by the Ca2+/calmodulin-dependent protein kinase inhibitor 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-trosyl]-4-phenylpiperazin e (KN-62).
    Puhl HL; Raman PS; Williams CL; Aronstam RS
    Biochem Pharmacol; 1997 Apr; 53(8):1107-14. PubMed ID: 9175715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
    Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
    J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
    Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
    Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.
    Brozinick JT; Reynolds TH; Dean D; Cartee G; Cushman SW
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):533-40. PubMed ID: 10215590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.